MPTP-INDUCED BEHAVIORAL AND BIOCHEMICAL DEFICITS - A PARAMETRIC ANALYSIS

被引:73
作者
FREDRIKSSON, A
ARCHER, T
机构
[1] UNIV GOTHENBURG,DEPT PSYCHOL,S-40020 GOTHENBURG,SWEDEN
[2] UPPSALA UNIV,DEPT TOXICOL,UPPSALA,SWEDEN
关键词
MPTP; DOSE; TEST INTERVAL; DOPAMINE; LOCOMOTION; REARING; TOTAL ACTIVITY; MICE;
D O I
10.1007/BF02260967
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Two experiments were performed to study the parametric effects of long-term administration of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), as a functional model of parkinsonism in mice. The behavioural deficits induced by different doses of MPTP (5, 10, 20, 30 or 40 mg/kg, s.c., each injected on two occasions) at a 3-week or a 3-month treatment-testing interval were evidenced by significant reductions of spontaneous motor activity, from the 10 mg/kg dosages upwards at the 3-week interval and from 30-40 mg/kg at the 3-month interval. Significant dopamine (DA) reductions in the mouse striatum were obtained at these dose levels and intervals. The behavioural deficit of the 40 mg/kg dose (injected on two occasions) and tested at the 3-, 6-, 12-, 24- and 40-week intervals (separate as well as repeated testing groups) indicated marked and relatively comparable reductions of all three parameters of motor activity, locomotion, rearing and total activity. DA depletions were severe at all five test intervals. These results offer functional and neurochemical evidence that MPTP treatment produces permanent damage to the nigrostriatal motor system in mice.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 33 条
  • [1] EVALUATION OF A 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-TREATED C57 BLACK MOUSE MODEL FOR PARKINSONISM
    ARAI, N
    MISUGI, K
    GOSHIMA, Y
    MISU, Y
    [J]. BRAIN RESEARCH, 1990, 515 (1-2) : 57 - 63
  • [2] CENTRAL NORADRENALINE DEPLETION ANTAGONIZES ASPECTS OF D-AMPHETAMINE-INDUCED HYPERACTIVITY IN THE RAT
    ARCHER, T
    FREDRIKSSON, A
    JONSSON, G
    LEWANDER, T
    MOHAMMED, AK
    ROSS, SB
    SODERBERG, U
    [J]. PSYCHOPHARMACOLOGY, 1986, 88 (02) : 141 - 146
  • [3] A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    BURNS, RS
    CHIUEH, CC
    MARKEY, SP
    EBERT, MH
    JACOBOWITZ, DM
    KOPIN, IJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14): : 4546 - 4550
  • [4] EFFECTS OF CLASSICAL AND NOVEL AGENTS IN A MPTP-INDUCED REVERSIBLE MODEL OF PARKINSONS-DISEASE
    CLOSE, SP
    ELLIOTT, PJ
    HAYES, AG
    MARRIOTT, AS
    [J]. PSYCHOPHARMACOLOGY, 1990, 102 (03) : 295 - 300
  • [5] DUVOISIN RC, 1986, RECENT DEV PARKINSON, P147
  • [6] MPTP-INDUCED HYPOACTIVITY IN MICE - REVERSAL BY L-DOPA
    FREDRIKSSON, A
    PLAZNIK, A
    SUNDSTROM, E
    JONSSON, G
    ARCHER, T
    [J]. PHARMACOLOGY & TOXICOLOGY, 1990, 67 (04): : 295 - 301
  • [7] BEHAVIORAL-EFFECTS OF ANGIOTENSIN-II IN THE MOUSE FOLLOWING MPTP ADMINISTRATION
    GEORGIEV, V
    KAMBOUROVA, T
    [J]. GENERAL PHARMACOLOGY, 1991, 22 (04): : 625 - 630
  • [8] AGED MICE ARE MORE SENSITIVE TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE TREATMENT THAN YOUNG-ADULTS
    GUPTA, M
    GUPTA, BK
    THOMAS, R
    BRUEMMER, V
    SLADEK, JR
    FELTEN, DL
    [J]. NEUROSCIENCE LETTERS, 1986, 70 (03) : 326 - 331
  • [9] NEUROCHEMICAL AND HISTOCHEMICAL CHARACTERIZATION OF NEUROTOXIC EFFECTS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE ON BRAIN CATECHOLAMINE NEURONS IN THE MOUSE
    HALLMAN, H
    LANGE, J
    OLSON, L
    STROMBERG, I
    JONSSON, G
    [J]. JOURNAL OF NEUROCHEMISTRY, 1985, 44 (01) : 117 - 127
  • [10] SOME FEATURES OF THE NIGROSTRIATAL DOPAMINERGIC NEUROTOXIN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN THE MOUSE
    HEIKKILA, RE
    SIEBER, BA
    MANZINO, L
    SONSALLA, PK
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1989, 10 (03) : 171 - 183